Loading…
P3 Health Partners Inc. is projected to rise to $17.36 by 2027, a +9% move from its current price of $15.93. PIII is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $14.44 | $15.95 | $17.61 | +0.10% |
| May 30 | $13.87 | $15.96 | $18.37 | +0.21% |
| May 31 | $13.45 | $15.98 | $18.98 | +0.31% |
| Jun 1 | $13.11 | $16.00 | $19.51 | +0.41% |
| Jun 2 | $12.82 | $16.01 | $19.99 | +0.51% |
| Jun 3 | $12.57 | $16.03 | $20.44 | +0.62% |
| Jun 4 | $12.34 | $16.04 | $20.87 | +0.72% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $12.34 | $16.04 | $20.87 | +0.72% |
| Week 2 | $11.15 | $16.16 | $23.43 | +1.45% |
| Week 3 | $10.33 | $16.28 | $25.66 | +2.18% |
| Week 4 | $9.69 | $16.39 | $27.73 | +2.91% |
| Week 5 | $9.18 | $16.51 | $29.71 | +3.65% |
| Week 6 | $8.74 | $16.63 | $31.65 | +4.40% |
| Week 7 | $8.36 | $16.75 | $33.57 | +5.15% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
P3 Health Partners Inc. is a healthcare company described as patient-centered and physician-led, focusing on population health management. It provides superior care services across clinics and wellness centers in the United States.
The company was founded in 2020 and is based in Henderson, Nevada. It operates within the Healthcare category and is identified by the stock symbol PIII.
PIII trades at $15.93 per share and has a market capitalization of $3.24B. It is ranked 1651 by market cap.
The forecast implies a near-term flat path with a 2026 average price of $15.93 and neutral sentiment. The 2026 avg is $15.93 with ROI 0%.
From 2027 onward, the model envisions a steady rise in average price, finishing with a 2050 average price of $132.55 and a maximum of $304.87, with a long-run bullish tilt and ROI up to 732.1%. The 2050 max is $304.87.
The 30-day price range spans $8.28 to $30.65, with a current resistance at $15.93 and a support at $2.44, illustrating notable near-term volatility. The 30-day range is $8.28-$30.65.
A major floor 90.5% below — a decisive break under it would weaken the trend.
The nearest floor, 84.7% below — buyers have tended to step in here.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major ceiling 56.5% above — clearing it would confirm fresh momentum.
Key PIII support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of PIII market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $13.13 | Buy | $13.25 | Buy |
| MA 10 | $10.42 | Buy | $11.01 | Buy |
| MA 20 | $6.80 | Buy | $8.32 | Buy |
| MA 50 | $4.35 | Buy | $5.53 | Buy |
| MA 100 | $3.47 | Buy | $4.71 | Buy |
| MA 200 | $5.38 | Buy | $5.76 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 80.17 | Sell |
| Stoch RSI (14) | 53.19 | Neutral |
| CCI (20) | 144.16 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 1.03 | Buy |
| ROC (12) | 348.99 | Buy |
| Bollinger %B (20,2) | 1.00 | Sell |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 7.13 | Buy |
| Awesome (5,34) | 8.05 | Buy |
| Ultimate (7,14,28) | 73.98 | Sell |
| Momentum (10) | 12.16 | Buy |
| Aroon Osc (25) | 88.00 | Buy |
| Hull MA (9) | 15.18 | Buy |
| ADX (14) | 36.71 | Buy |
| ATR (14) | 1.11 | Info |
The near-term technical picture is bullish, with RSI14 at 80, suggesting strong upward momentum.
Key moving averages show SMA50 at $4.35 and SMA200 at $5.38. Near-term support is at $2.44 and resistance at $15.93, indicating a potential pause around the current price level.
The stock has traded in a 30-day range of $8.28 to $30.65, reflecting notable volatility over the period.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.52 | $15.93 | $22.61 | 0% | Neutral | |
| $12.49 | $17.36 | $26.10 | +9% | Neutral | |
| $14.40 | $21.23 | $33.93 | +33% | Bullish | |
| $17.46 | $27.10 | $45.41 | +70% | Bullish | |
| $18.64 | $30.32 | $52.85 | +90% | Bullish | |
| $20.34 | $34.56 | $62.34 | +117% | Bullish | |
| $17.67 | $31.32 | $58.21 | +97% | Bullish | |
| $15.81 | $29.17 | $55.72 | +83% | Bullish | |
| $17.84 | $34.24 | $67.03 | +115% | Bullish | |
| $19.59 | $39.08 | $78.27 | +145% | Bullish | |
| $23.98 | $53.28 | $117.20 | +234% | Bullish | |
| $59.65 | $132.55 | $304.87 | +732% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $1.52 | $15.93 | $18.98 | +0.00% |
| June 2026 | $14.22 | $17.06 | $21.20 | +7.08% |
| July 2026 | $14.34 | $17.49 | $22.29 | +2.54% |
| August 2026 | $13.31 | $16.45 | $21.37 | -5.97% |
| September 2026 | $13.09 | $16.35 | $21.58 | -0.56% |
| October 2026 | $13.72 | $17.32 | $23.17 | +5.89% |
| November 2026 | $13.42 | $17.10 | $23.16 | -1.28% |
| December 2026 | $12.84 | $16.51 | $22.61 | -3.45% |
Click any year to see its month-by-month PIII forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The PIII price prediction for 2026 points to an average of $15.93 (low $1.52, high $22.61) — a potential gain of 0% on today's $15.93. Price action looks broadly range-bound.
In 2027, PIII is projected to trade between $12.49 and $26.10, averaging $17.36 — a potential gain of +9% from today's $15.93. That is up +9% on the projected 2026 average. A consolidation phase looks the most probable path here.
P3 Health Partners Inc.'s 2028 outlook centres on $21.23, within a $14.40 to $33.93 range. That is up +22% on the projected 2027 average. That marks a +33% change versus current levels. Momentum favours further upside here.
By 2029, PIII could reach as high as $45.41, with a base case around $27.10 and support toward $17.46 — roughly +70% from $15.93. Buyers look set to stay in control over this stretch.
Expect PIII to range from $18.64 to $52.85 through 2030. The $30.32 average target implies a +90% move from current prices. That is up +12% on the projected 2029 average. Momentum favours further upside here.
The PIII price prediction for 2031 points to an average of $34.56 (low $20.34, high $62.34) — a potential gain of +117% on today's $15.93. Buyers look set to stay in control over this stretch.
In 2032, PIII is projected to trade between $17.67 and $58.21, averaging $31.32 — a potential gain of +97% from today's $15.93. That is -9% versus the projected 2031 average. Momentum favours further upside here.
P3 Health Partners Inc.'s 2033 outlook centres on $29.17, within a $15.81 to $55.72 range. That is -7% versus the projected 2032 average. That marks a +83% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, PIII could reach as high as $67.03, with a base case around $34.24 and support toward $17.84 — roughly +115% from $15.93. Momentum favours further upside here.
Expect PIII to range from $19.59 to $78.27 through 2035. The $39.08 average target implies a +145% move from current prices. That is up +14% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The PIII price prediction for 2040 points to an average of $53.28 (low $23.98, high $117.20) — a potential gain of +234% on today's $15.93. Momentum favours further upside here.
In 2050, PIII is projected to trade between $59.65 and $304.87, averaging $132.55 — a potential gain of +732% from today's $15.93. That is up +149% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in PIII today (≈ 62.774639 PIII) could be worth
$8,320.79
+$7,320.79 (+732%) by 2050 · US Dollar
Based on the average projected PIII price of $132.55 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in PIIIwould be worth at today's price.
$1,000 invested in PIII on May 27, 2025 (≈ 137.741042 PIII) would be worth
$2,194.21
+$1,194.21 (+119.4%) today · 2.19× · US Dollar
Based on a PIII entry price of $7.26 vs. today's $15.93.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $9.69 | $1,643.96 | +64.4% |
| 1 month ago | $2.7 | $5,900 | +490.0% |
| 3 months ago | $2.22 | $7,175.68 | +617.6% |
| 6 months ago | $5.4 | $2,950 | +195.0% |
| 1 year ago | $7.26 | $2,194.21 | +119.4% |
| All time (5.0y) ago | $497.25 | $32.04 | -96.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our PIII forecast.
Our base-case forecast reaches $32.00 around 2031.
Implied market cap at $32.00: $106.43M
The multi-year forecast shows a long runway for upside with bullish sentiment from 2027 onward. The 2030 average price is $30.32, the 2040 average is $53.28, and the 2050 average climbs to $132.55, with corresponding ROIs of 90.3% and 234.5% and ultimately 732.1% by 2050.
By 2050 the forecasted maximum price reaches $304.87, underscoring substantial longer-term upside in the modeled path. The sequence includes continued bullish episodes through 2031-2035 and beyond, with rising averages each step of the way.
These forecasts are estimates and not guarantees; actual results depend on market conditions and other factors. The numbers reflect modeled pathways and are intended to inform perspective rather than promise outcomes.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $30.32, with a min of $18.64 and a max of $52.85, and a return on investment of about 90.3% with bullish sentiment.
The forecast indicates bullish sentiment in several years, with the 2050 average at $132.55 and a max of $304.87, yielding an upside of about 732.1% in that horizon; however, these are estimates and not guarantees.
Yes. The projection shows a maximum of $304.87 by 2050, which exceeds $100, with the 2050 average at $132.55 and a bullish outlook.
Current price is $15.93 and the market cap is $3.24B.
The 30-day picture is bullish with RSI 80. SMA50 is $4.35 and SMA200 is $5.38. Support is at $2.44 and resistance at $15.93. The 30-day range spans $8.28 to $30.65.
P3 Health Partners Inc. Community Discussion
0Share your P3 Health Partners Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.